Stergios Zacharoulis, MD

Expertise in: 
Pediatric Hematology-Oncology
Accepting New Patients
Treats Children

Overview

Areas of Expertise / Conditions Treated

Brain Stem Glioma, Central Nervous System Tumors, Chemotherapy Infusion, Neuro-Oncology, Pediatric Brain Tumors, Pediatric Neuro-Oncology

Academic Appointments

  • Associate Professor of Pediatrics at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Morgan Stanley Children's Hospital

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Aristotelian University of Thessaloniki (Greece)
  • Internship: Yale-New Haven Hospital
  • Residency: State University of New York Upstate Medical Center
  • Fellowship: Dana Farber Cancer Institute
  • Fellowship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: Memorial Sloan-Kettering Cancer Center

Research

Grants

A PHASE I STUDY EXAMINING THE FEASIBILITY OF INTERMITTENT CONVECTION-ENHANCED DELIVERY (CED) OF MTX110 FOR THE TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED DIFFUSE MIDLINE GLIOMAS (P&S Industry Clinical Trial)

Mar 2 2020 - Mar 2 2025

PHASE IB /II CLINICAL TRIAL OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN PEDIATRIC SUBJECTS WITH HIGH GRADE PRIMARY CNS MALIGNANCIES (P&S Industry Clinical Trial)

Aug 2 2017 - Aug 2 2022

A PHASE 1/1B, OPEN LABEL, DOSE ESCALATION AND EXPANSION STUDY OF ENTRECTINIB (RXDX-101) IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS AND PRIMARY CNS TUMORS WIHT OR WIHTOUT TRK,ROS1 OR LAK FUSIONS (P&S Industry Clinical Trial)

Jun 9 2017 - Jun 9 2022

A PHASE 1, MULTI-CENTER, OPEN-LABEL, DOSE DE-ESCALATION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TALIMOGENE LAHERPAREPVEC IN PEDIATRIC SUBJECTS WITH ADVANCED NON CENTRAL NERVOUS SYSTEM TUMORS THAT ARE AMENABLE TO DIRECT INJECTION (P&S Industry Clinical Trial)

Jun 16 2016 - Jun 16 2021

TARGETING MASTER REGULATOR DEPENDENCIES IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (Private)

Dec 1 2019 - Dec 31 2020